The HSJ Medicines Forum was sponsored by the following industry partners: BIAL, Daichii Sankyo, Optum, Sandoz, Spirit Health, Accord, ALTURiX and Novartis. Four partners had responsibility for their individual workshop sessions. They had no editorial involvement in the broader agenda, which HSJ retained full control and responsibility for.

 

Driving efficiency and value in an integrated care landscape

The new integrated care landscape ushers in changes for most healthcare professionals, but the impact for pharmacy is particularly marked. ISC/ICB Chief Pharmacists are now looking after medicines across primary and secondary care and working with community pharmacy and in care settings.

Pharmacy teams are also taking on more specialised commissioning responsibilities, implementing pharmacy first, having to handle shortages and supply chain problems, taking a lead on digitisation and e-prescribing, and addressing prescribing and population health management in the context of reducing health inequalities.

The HSJ Medicines Forum will bring together senior leaders responsible for establishing the new medicines and prescribing operating framework across the ICS. Through interactive panel discussions and roundtables, this event will facilitate an exchange of strategy and approach – and examine the opportunities to optimise value and patient outcomes in this new environment

What our delegates say

" Excellent initiative bringing together leaders to debate future opportunities for medicines optimisation "
" Informative, interactive day where pharmaceutical colleagues came together to better understand medicines optimisation programmes of care "
" Excellent and informative, great to learn and share best practice, progress and challenges from other colleagues "
" A great forum to discuss and understand the practicalities surrounding implementation of medicines related policies/initiatives within the new ICS "

To find out more

Partnership opportunities:  Sponsorship Sales team
Delegate enquiries: Delegate Sales team